The effect of previous SARS-CoV-2 infection on systemic immune responses in individuals with tuberculosis.

Saved in:
Bibliographic Details
Title: The effect of previous SARS-CoV-2 infection on systemic immune responses in individuals with tuberculosis.
Authors: Xavier MS; Pós-graduação em Pesquisa Clínica em Doenças Infecciosas, Instituto Nacional de Infectologia Evandro Chagas, FIOCRUZ, Rio de Janeiro, Brazil., Araujo-Pereira M; Laboratório de Pesquisa Clínica e Translacional, Instituto Gonçalo Moniz, FIOCRUZ, Bahia, Brazil.; Curso de Medicina, Faculdade ZARNS, Bahia, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research Initiative, Bahia, Brazil., de Oliveira QM; Laboratório de Pesquisa Clínica em Micobacterioses, Instituto Nacional de Infectologia Evandro Chagas, FIOCRUZ, Rio de Janeiro, Brazil., Sant'Anna FM; Laboratório de Pesquisa Clínica em Micobacterioses, Instituto Nacional de Infectologia Evandro Chagas, FIOCRUZ, Rio de Janeiro, Brazil., Ridolfi FM; Laboratório de Pesquisa Clínica em Micobacterioses, Instituto Nacional de Infectologia Evandro Chagas, FIOCRUZ, Rio de Janeiro, Brazil., de Andrade AMS; Multinational Organization Network Sponsoring Translational and Epidemiological Research Initiative, Bahia, Brazil., Figueiredo MC; Vanderbilt University Medical Center, Department of Medicine, Division of Infectious Diseases, Nashville, TN, United States., Sterling TR; Vanderbilt University Medical Center, Department of Medicine, Division of Infectious Diseases, Nashville, TN, United States., Gordhan BG; Department of Science and Innovation/National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand and the National Health Laboratory Service, Johannesburg, South Africa., Kana BD; Department of Science and Innovation/National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand and the National Health Laboratory Service, Johannesburg, South Africa., Andrade BB; Laboratório de Pesquisa Clínica e Translacional, Instituto Gonçalo Moniz, FIOCRUZ, Bahia, Brazil.; Curso de Medicina, Faculdade ZARNS, Bahia, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research Initiative, Bahia, Brazil., Rolla VC; Laboratório de Pesquisa Clínica em Micobacterioses, Instituto Nacional de Infectologia Evandro Chagas, FIOCRUZ, Rio de Janeiro, Brazil., Gomes-Silva A; Laboratório de Pesquisa Clínica em Micobacterioses, Instituto Nacional de Infectologia Evandro Chagas, FIOCRUZ, Rio de Janeiro, Brazil.; Laboratório Interdisciplinar de Pesquisas Médicas, Instituto Oswaldo Cruz, FIOCRUZ, Rio de Janeiro, Brazil.
Source: Frontiers in immunology [Front Immunol] 2024 Jun 27; Vol. 15, pp. 1357360. Date of Electronic Publication: 2024 Jun 27 (Print Publication: 2024).
Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2024.1357360